Use access key #2 to skip to page content.
$8.17 -0.06 (-0.69%)
8/20/2008 3:07 PM

AMERICAN ORIENTL BIO (AOB)

CAPS Rating:
****

The Company, together with its wholly owned subsidiaries, is a pharmaceutical and Traditional Chinese Medicine company which develops, manufactures and commercializes both plant-based pharmaceutical and plant-based nutraceutical products.

View Ticker Page (AOB)

Results 21 - 30 of 254 :   12345Next »

Recs

2

Avatar guitarwrecker (< 20) Submitted: 4/15/07 10:38 PM : Outperform Start Price: $10.42 AOB Score: -8.58

Co. seeing great growth in China and now line of products shipping internationally to China. Great balance sheet - very little debt, has the ability to acquire smaller co's such as they did in 2006. Revenue growth looks good. And it just got hit, ...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar Xandamere (38.64) Submitted: 6/08/08 7:12 PM : Outperform Start Price: $9.00 AOB Score: -0.27

Extremely cheap for a company growing as fast as it is and with the kind of margins it commands. No debt, strong cash position, this company mints money and is outcompeting its peers in a growing market. Not as cheap as some of the other Chinese sele...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar lewinste (98.02) Submitted: 5/25/07 11:25 AM : Outperform Start Price: $10.88 AOB Score: -8.49

Good fundementals, rapid growth, no debt.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar stockreader (34.61) Submitted: 1/18/08 11:33 AM : Outperform Start Price: $9.69 AOB Score: -10.19

AOB is very well positioned to take advantage of the fragmented Chinese traditional medicine market. The company is very experienced when it comes to buying and integrating smaller companies. I believe AOB can maintain growth in range of 30 to 50 per...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar microcaps9 (< 20) Submitted: 5/12/07 2:41 PM : Outperform Start Price: $11.05 AOB Score: -10.15

Who knows??

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar Creekdoc (71.24) Submitted: 5/10/07 6:40 PM : Outperform Start Price: $10.90 AOB Score: -9.75

Rapidly growing biotech company in China - the stock is undervalued for its industry - no debt - rising revenues and healthy, consistent margins - expansion - could become an international powerhouse - lots of room for growth

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar ref788 (21.88) Submitted: 5/03/07 9:16 AM : Outperform Start Price: $10.06 AOB Score: -3.37

promising biotech

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar MichiganBull (63.03) Submitted: 1/07/08 1:20 PM : Outperform Start Price: $10.31 AOB Score: -10.16

Chinese medicine

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar dash21 (< 20) Submitted: 1/07/08 2:38 PM : Outperform Start Price: $10.35 AOB Score: -10.86

Strong insider ownership, net cash position, history of accretive acquisitions, growing healthcare mkt in China/Asia

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar danfbarrett7 (< 20) Submitted: 4/19/07 11:04 PM : Outperform Start Price: $10.76 AOB Score: -9.65

stock down due to china markets. great fundamentals: no debt, 27% pm,PEG .57, strong cash flow, not followed on street, 28% insider ownership, only trading 14 times 2008 est or .75/share. Stock is a double over 12-18 months.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners